SuperworthElanco Animal Health market cap ELAN
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $11.3B
- Highest close in our data
- $17.3B
- Jul 2021
Elanco Animal Health is worth $11.3B at the close on Oct 23, 2026, at $22.52 a share.
That is up 3% over the last year and down 28% over five years.
Its highest close in our data was $17.3B in Jul 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $11.3B | $9.9B | $13.2B | +0% |
| 2025 | $11.2B | $4.2B | $11.6B | +88% |
| 2024 | $6B | $5.7B | $9B | −19% |
| 2023 | $7.3B | $4.1B | $7.3B | +27% |
| 2022 | $5.8B | $5.6B | $13.2B | −57% |
| 2021 | $13.4B | $13.1B | $17.3B | −7% |
| 2020 | $14.5B | $7B | $14.8B | +32% |
| 2019 | $10.9B | $9.7B | $12.5B | −4% |
| 2018 | $11.5B | $11B | $12.6B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Elanco Animal Health's size, closest first, today.
| Company | Market cap |
|---|---|
| ELANElanco Animal Health | $11.3B |
| BMRNBiomarin Pharmaceutical | $10.8B |
| CORTCorcept Therapeutics | $9.3B |
| JAZZJazz Pharmaceuticals | $13.9B |
| PTGXProtagonist Therapeutics | $9B |
| TGTXTG Therapeutics | $8.3B |
| ALKSAlkermes plc. | $7.3B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| LGNDLigand Pharmaceuticals | $6.1B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| INDVIndivior Pharmaceuticals | $4.1B |
| Peer median | $7.8B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Elanco Animal Health
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.